Esperion Therapeutics
ESPR
#6663
Rank
HK$6.43 B
Marketcap
HK$24.95
Share price
0.00%
Change (1 day)
31.96%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): HK$0.61 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are HK$0.41 Billion. In 2025 the company made an earning of HK$0.50 Billion, an increase over its 2024 earnings that were of HK$58.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$0.61 B23.49%
2025 HK$0.50 B749.49%
2024 HK$58.9 M-104.99%
2023 -HK$1.18 Billion-15.03%
2022 -HK$1.39 Billion-20.61%
2021 -HK$1.75 Billion84.28%
2020 -HK$0.95 Billion35.75%
2019 -HK$0.7 Billion-55.71%
2018 -HK$1.58 Billion19.57%
2017 -HK$1.32 Billion125.39%
2016 -HK$0.59 Billion51.43%
2015 -HK$0.39 Billion36.45%
2014 -HK$0.29 Billion43.55%
2013 -HK$0.2 Billion145.26%
2012 -HK$80.48 Million
2002 -HK$0.23 Billion-7.81%
2001 -HK$0.25 Billion15.03%
2000 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.20 B 8,600.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.53 B 6,407.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$3.97 Billion-736.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$0.48 Billion-176.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$1.49 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$1.17 B 87.82%๐Ÿ‡บ๐Ÿ‡ธ USA